跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Yupelri - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Yupelri
Approved
STANDARD
Yupelri
The Ritedose Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3075614dc8046500
Company
The Ritedose Corporation
Type
Standard
Approval Details
Approval Id
3075614dc8046500
Drug Approval Philippines Name
Yupelri
Product Name
Yupelri
Registration Number
DR-XY48387
Brand Name
Yupelri
Generic Name
Revefenacin
Dosage Form
Solution for Inhalation
Dosage Strength
175mcg/3mL
Manufacturer
The Ritedose Corporation
Importer
Viatris Pharmaceuticals, Inc.
Distributor
Viatris Pharmaceuticals, Inc.
Company Detail Path
/organization/the-ritedose-corporation
Issuance Date
03 October 2022
Expiry Date
03 October 2027
Pharmacologic Category
Anticholinergic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3075614dc8046500
Type
Standard
Back to Philippines FDA Approvals